We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Nice
NICE
$6.01B
| $63K | ﹤0.01% |
276
| – | – |
|
552
Ulta Beauty
ULTA
$23.6B
| $63K | ﹤0.01% |
115
-660
| -85% | -$339K |
|
|
NSA
553
DELISTED
National Storage Affiliates Trust
NSA
| $62K | ﹤0.01% |
1,491
-1,999
| -57% | -$80.9K |
|
554
Zebra Technologies
ZBRA
$17.9B
| $62K | ﹤0.01% |
+196
| New | +$59.2K |
|
555
Dow Inc
DOW
$22.1B
| $61K | ﹤0.01% |
1,112
-426
| -28% | -$24K |
|
556
Gen Digital
GEN
$17.5B
| $61K | ﹤0.01% |
3,546
-12,857
| -78% | -$258K |
|
|
GRMN
557
Garmin
GRMN
$60.4B
| $61K | ﹤0.01% |
600
+355
| +145% | +$34.7K |
|
558
Baker Hughes
BKR
$63.6B
| $60K | ﹤0.01% |
2,076
| – | – |
|
559
NiSource
NI
$20B
| $60K | ﹤0.01% |
2,145
+344
| +19% | +$9.41K |
|
560
Palo Alto Networks
PANW
$314B
| $59K | ﹤0.01% |
596
-5,166
| -90% | -$438K |
|
561
Dynatrace
DT
$14.6B
| $58K | ﹤0.01% |
1,378
-290
| -17% | -$11.7K |
|
562
Edison International
EIX
$26.1B
| $58K | ﹤0.01% |
827
-2,666
| -76% | -$180K |
|
563
W.R. Berkley
WRB
$26.3B
| $58K | ﹤0.01% |
1,400
-3,676
| -72% | -$164K |
|
564
CoStar Group
CSGP
$12.8B
| $56K | ﹤0.01% |
824
-217
| -21% | -$16K |
|
565
Tyson Foods
TSN
$20.1B
| $56K | ﹤0.01% |
+945
| New | +$58K |
|
566
Zoetis
ZTS
$30.9B
| $56K | ﹤0.01% |
335
+239
| +249% | +$39.2K |
|
567
Carlisle Companies
CSL
$15.3B
| $55K | ﹤0.01% |
245
+181
| +283% | +$44K |
|
568
Jack Henry & Associates
JKHY
$11B
| $55K | ﹤0.01% |
362
+175
| +94% | +$29.2K |
|
569
SPDR Gold Trust
GLD
$143B
| $54K | ﹤0.01% |
292
-1,819
| -86% | -$320K |
|
570
Nucor
NUE
$62.5B
| $54K | ﹤0.01% |
352
-1,752
| -83% | -$279K |
|
571
Wabtec
WAB
$49.7B
| $54K | ﹤0.01% |
534
+266
| +99% | +$27.2K |
|
572
Moody's
MCO
$82.8B
| $53K | ﹤0.01% |
173
+71
| +70% | +$21.5K |
|
|
WCN
573
Waste Connections
WCN
$41.9B
| $53K | ﹤0.01% |
383
-64
| -14% | -$8.52K |
|
574
Arch Capital
ACGL
$33.5B
| $52K | ﹤0.01% |
+759
| New | +$49.9K |
|
575
Avery Dennison
AVY
$13.5B
| $52K | ﹤0.01% |
293
| – | – |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.